Literature DB >> 8747534

A quick procedure for the isolation of dimeric piratoxins-I and II, two myotoxins from Bothrops pirajai snake venom. N-terminal sequencing.

M H Toyama1, L C Mancuso, J R Giglio, J C Novello, B Oliveira, S Marangoni.   

Abstract

Two myotoxins, MP-I and MP-II, from Bothrops pirajai snake venom, have been purified by a quick high performance liquid chromatography (HPLC) procedure. Based on the HPLC coelution profile, amino acid composition, N-terminal sequence, polyacrylamide gel electrophoresis (PAGE) migration, as well as lack of phospholipase-A2 (PLA2) and proteolytic activities, MP-I and MP-II were identified as piratoxin-I (PrTX-I) and II (PrTX-II), respectively. This procedure affords, aside the reduced operation time, a high yield (35% of the applied sample in terms of A280nm) of MP-I, which is the major myotoxin of the venom. The N-terminal sequences of MP-I, MP-II, PrTX-I and PrTX-II, up to the 51st, 41st, 46th and 39th residues, respectively, have been determined, revealing MP-I (and hence PrTX-I) as a Lys-49 PLA2-like myotoxin. Both MP-I and MP-II have been shown, by SDS-PAGE, to occur in dimeric isoforms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747534

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  8 in total

1.  Determination of primary structure of two isoforms 6-1 and 6-2 PLA2 D49 from Bothrops jararacussu snake venom and neurotoxic characterization using in vitro neuromuscular preparation.

Authors:  L A Ponce-Soto; V L Bonfim; L Rodrigues-Simioni; J C Novello; S Marangoni
Journal:  Protein J       Date:  2006-02       Impact factor: 2.371

2.  Structural and functional properties of Cr 5, a new Lys49 phospholipase A2 homologue isolated from the venom of the snake Calloselasma rhodostoma.

Authors:  V L Bonfim; L A Ponce-Soto; J C Novello; S Marangoni
Journal:  Protein J       Date:  2006-12       Impact factor: 2.371

3.  Structural characterization and neuromuscular activity of a new Lys49 phospholipase A(2) homologous (Bp-12) isolated from Bothrops pauloensis snake venom.

Authors:  Priscila Randazzo-Moura; L A Ponce-Soto; Léa Rodrigues-Simioni; Sérgio Marangoni
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

4.  Isolation and characterization of a serine protease, Ba III-4, from Peruvian Bothrops atrox venom.

Authors:  L A Ponce-Soto; V L Bonfim; J C Novello; R Navarro Oviedo; A Yarlequé Chocas; S Marangoni
Journal:  Protein J       Date:  2007-09       Impact factor: 2.371

5.  Isolation and biochemical characterization of a new thrombin-like serine protease from Bothrops pirajai snake venom.

Authors:  Kayena D Zaqueo; Anderson M Kayano; Rodrigo Simões-Silva; Leandro S Moreira-Dill; Carla F C Fernandes; André L Fuly; Vinícius G Maltarollo; Kathia M Honório; Saulo L da Silva; Gerardo Acosta; Maria Antonia O Caballol; Eliandre de Oliveira; Fernando Albericio; Leonardo A Calderon; Andreimar M Soares; Rodrigo G Stábeli
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

6.  PLA2-like proteins myotoxic mechanism: a dynamic model description.

Authors:  Rafael J Borges; Ney Lemke; Marcos R M Fontes
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

7.  Modulation of the pharmacological activities of secretory phospholipase A2 from Crotalus durissus cascavella induced by naringin.

Authors:  Marcelo L Santos; Daniela O Toyama; Simone C B Oliveira; Camila A Cotrim; Eduardo B S Diz-Filho; Fábio H R Fagundes; Veronica C G Soares; Ricardo Aparicio; Marcos H Toyama
Journal:  Molecules       Date:  2011-01-18       Impact factor: 4.411

8.  Modulation of the pharmacological effects of enzymatically-active PLA2 by BTL-2, an isolectin isolated from the Bryothamnion triquetrum red alga.

Authors:  Simone Cb Oliveira; Fabiana V Fonseca; Edson Antunes; Enilton A Camargo; Rafael P Morganti; Ricardo Aparício; Daniela O Toyama; Luís Os Beriam; Eudismar V Nunes; Benildo S Cavada; Celso S Nagano; Alexandre H Sampaio; Kyria S Nascimento; Marcos H Toyama
Journal:  BMC Biochem       Date:  2008-06-06       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.